GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

359 papers

Showing 181-192 of total 359 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

Comparative Efficacy and Safety of Tirzepatide Versus Semaglutide for Obesity: A Systematic Review.

Mohamed Abdalla SA; Gharbawi L; Elshaikh N; Elfaki Omer EO; Osman AFM; Hassan Ali AS; Yousif Mohamed TM; Alhajri AHM

2026PubMedDirectly related

Beyond Fat Loss: Addressing the Sarcopenia Challenge of Incretin-Based Therapies.

Kim JY; Kim NH

Jan 1, 2026Diabetes & metabolism journal

2026PubMedDirectly related

Obesity and Cardio-Metabolic Health in Kidney Disease: Implications for Kidney Health, Risk Stratification, and Management.

Mathew RO; Hong A; Narasaki Y; Fung E; Cheung D; Han J; Durstenfeld MS; Hsue PY; Rhee CM

Jan 1, 2026Clinical journal of the American Society of Nephrology : CJASN

2026PubMedDirectly related

Evidence-based ranking of diabetes prevention in prediabetes: A comprehensive network meta-analysis of 378 randomised controlled trials.

Maria B; Orsolya E; Iulian PR; Mihaela T; Aphrodite BA; Anett R; Tamás K; Karen F; Mahmoud O; Renáta P; Péter F; Andrea S; Cristian G; Peter H; Stefania B

Jan 1, 2026Clinical and translational medicine

2026PubMedDirectly related

Postpartum GLP-1 receptor agonists and SGLT-2 therapies in women with prior gestational diabetes: current evidence and uncertainties.

Vanlaer Y; Van de Cauter E; Embo N; Benhalima K

Jan 1, 2026BMC medicine

2026PubMedDirectly related

Acute pancreatitis following semaglutide therapy: a case report.

Alduraibi RK; Fattouta NA; Altowayan YF

Jan 1, 2026Annals of medicine and surgery (2012)

2026PubMedDirectly related

Preoperative GLP-1 receptor agonist use and outcomes after total hip arthroplasty: a matched cohort study.

Diab AR; Chang THW; Diab O; Kheir MM

Jan 1, 2026Hip international : the journal of clinical and experimental research on hip pathology and therapy

2026PubMedDirectly related

Metabolic Effects of a GLP-1 Analog Combined with Aerobic Training in Ovariectomized Rats.

Selau B; Bastos LM; Normann RS; Cubas GK; Herrmann ROCDC; Barros LDAO; de Amaral M; Trapp M; Kucharski LC; Vogt ÉL; Model JFA; Vinagre AS

Jan 1, 2026Molecular and cellular endocrinology

2026PubMedDirectly related

Assessing the Effects of Childhood and Adult Body Mass Index on Diabetic Retinopathy Risk: A Mendelian Randomization Study.

Gao L; Guo S; Zhu W; Zhou Y

Jan 1, 2026Endocrine, metabolic & immune disorders drug targets

2026PubMedDirectly related

Use of incretin receptor agonists in patients submitted to metabolic bariatric surgery - a systematic review and meta-analysis.

Santos-Pereira M; Frutuoso JF; Pereira SS; Guimarães M; Monteiro MP

Jan 1, 2026Frontiers in endocrinology

2026PubMedDirectly related

Where the Future Lies: GLP-1 Receptor Agonists as Therapeutics for Dermatologic Comorbidities.

DeCoster M; Narla S

Jan 1, 2026Clinics in dermatology

2026PubMedDirectly related

Effects of GLP-1 receptor agonists on the incidence of contrast-induced acute kidney injury in patients with Type 2 diabetes mellitus undergoing coronary interventions.

Oksen D; Aslan M; Yavuz YE; Kaynak C; Serin E

Jan 1, 2026Frontiers in endocrinology